A. Siddu

Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial

F. Cicchetti, L. David, H. L. Denis, 2019, Neurobiology of Disease.

Synaptogenic effect of APP-Swedish mutation in familial Alzheimer’s disease

T. Südhof, Marius Wernig, Bo Zhou, 2022, Science Translational Medicine.

Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's disease

M. Hayden, F. Cicchetti, O. Smrzka, 2020, Neurobiology of Disease.

Beneficial effects of cysteamine in Thy1-α-Syn mice and induced pluripotent stem cells with a SNCA gene triplication

F. Cicchetti, Melanie Alpaugh, M. Saint‐Pierre, 2020, Neurobiology of Disease.

Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model

F. Cicchetti, Frank Herrmann, C. Bazenet, 2023, Neurobiology of Disease.